News Detail
Mumbai, 20 Aug: The Drug Controller General of India (DCGI) has introduced a new set of guidelines to streamline the application process for conducting bioequivalence (BE) studies for export purposes in order to simplify the procedures and to bring in uniformity in decision making.
As......
View Details
Source : Pharmabiz
Related News
- Punjab: 15 patients experience mild reactions after IV fluid use in Sangrur hospital (14-03-2025)
- Trial of Offences must be conducted by a Court of Sessions, there is no bar on a Magistrate taking cognizance of such offences: Jammu and Kashmir and Ladakh HC (14-03-2025)
- Dr Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market (14-03-2025)
- Himachal: 1471 drugs samples failed quality tests in past two years: Minister in Assembly (14-03-2025)
- Licensing delays pushing medical device makers abroad: Parliament panel (14-03-2025)
- Four Smugglers Apprehended for Illicit Drug Sales; 2,930 Tablets Confiscated (14-03-2025)
- 2 antibiotic classes banned for use in animal rearing (13-03-2025)
- DoP organises workshop on PRIP Scheme (13-03-2025)
- Centre and States Prepare to Combat Narcotic Drug Abuse, May Require Barcodes on Packaging (13-03-2025)
- Large consignment of cough syrup recovered before Holi in Madhubani (13-03-2025)